The Global Epinephrine Auto-injector Market to Reach Revenues of Over $2 Billion During the Period 2020 -2025 - Market Research by Arizton
CHICAGO, April 23, 2020 /PRNewswire/ -- According to Arizton's recent research report, Epinephrine Auto-Injector Market - Global Outlook and Forecast 2020-2025 is expected to grow at a CAGR of approximately 9% during the period 2019-2025. This market research report includes data-driven and deep market insights on the impact of COVID-19 across geographies, segments, and vendor landscape. Leverage Arizton's market analysis to take real-time strategic business decisions and enhance your product portfolios.
https://mma.prnewswire.com/media/818553/Arizton_Logo.jpg
Key Highlights Offered in the Report:
1. Globally, the epinephrine auto-injectors market is estimated to grow at a
single digit rate of around 9% due to growing acceptance of epinephrine
auto-injectors as emergency treatment for anaphylaxis.
2. Greater availability of generic version of epinephrine auto-injectors
compared to branded one is expected to impact the market growth over the
forecast period.
3. Self-administration of anaphylaxis with safe, effective, and easy to use
epinephrine auto-injectors is gaining popularity globally, thus it is
becoming one of the key driving factors of the global epinephrine
auto-injectors market.
4. Many market players are focusing on several patient assistance programs
to offer a wide range of disease prevention practices and patient
education materials related to anaphylaxis.
5. North America is leading the global market and accounted for a share of
around 80% in 2019, followed by Europe, APAC, Middle East & Africa, and
Latin America.
6. Mylan is the market leader and offers innovative product line for
epinephrine auto-injector.
Key Offerings:
-- Market Size & Forecast by Revenue | 2019-2025
-- Market Dynamics - Leading trends, growth drivers, restraints, and
investment opportunities
-- Market Segmentation - A detailed analysis by dosage, age group,
end-user, and geography
-- Competitive Landscape - Profile of 3 key vendors and 6 other vendors
Get your sample today! https://www.arizton.com/market-reports/epinephrine-auto-injector-market
Epinephrine Auto-Injector Market - Segmentation
-- The growing incidence of anaphylaxis in adults, especially in the
elderly population, is the primary factor driving the growth of the high
dose segment. As epinephrine is considered as the first-line treatment
for anaphylaxis, the increasing recommendation of high dose by
healthcare professionals (HCP) across the globe for adult patients is
fueling the growth of the segment.
-- In 2019, the below 6 years segment accounted for a 10% market share of
the global epinephrine auto-injector market. Children in this age group
are prescribed to be treated with 0.15 mg/0.1 mg dose capacity. An
estimated 130% increase in emergency room visits for anaphylaxis among
children aged 4 years old and younger reported between 2005 and 2014.
-- HCPs in hospitals & clinics are using epinephrine auto-injectors for the
emergency management of anaphylaxis. The market is growing at a healthy
rate on account of the high adoption of these devices by emergency
departments in hospitals and clinics. The availability of skilled HCPs
with knowledge and expertise also attracts many patients to hospitals
and clinics.
Market Segmentation by Dosage
-- High
-- Low
Market Segmentation by Age Group
-- Below 6 Years
-- Between 6 & 12 years
-- Above 12 years
Market Segmentation by End-user
-- Hospitals & Clinics
-- Individuals
-- Others
Epinephrine Auto-Injector Market - Dynamics
Owing to the significant growth opportunity in the global epinephrine auto-injectors market, new and emerging market players are strategically focusing on the development of innovative solutions for anaphylaxis management. New product development, coupled with product innovations and R&D activities, helps new and emerging players to establish their presence, as well as enhance market growth and sustain their market position. Vendors are actively conducting clinical trials in order to gain regulatory approval in different countries. The existing epinephrine-auto injectors are mostly bigger in size that creates inconvenience while carrying such an emergency device. Also, user-friendliness or safety aspect is another drawback in existing epinephrine auto-injectors.
Key Drivers and Trends fueling Market Growth:
-- Vendors' Growing Focus on Patient Assistance Programs
-- Increasing Demand for Generic Epinephrine Auto-injectors at
Pharma/Retail Stores
-- Rising Incidence of Anaphylaxis
-- Growing Demand for Self-administration of Drugs
Epinephrine Auto-Injector Market - Geography
North America dominates the epinephrine auto-injector market. The presence of a large disease population, coupled with better access to treatment for anaphylaxis, is the primary factor for its high market share. The strong presence of key vendors is also another reason for high product uptake in the region. Moreover, the rise in the anaphylactic patient pool and the launch of generic substitutes, which help to treat the condition effectively in adults and children groups, are likely to boost the growth during the forecast period. Canada is likely to experience healthy growth during the forecast period. The market in the region is dominated by branded as well as generic epinephrine auto-injectors for the treatment of anaphylactic reaction. The availability of generic epinephrine auto-injectors is abundantly high in this region.
Get your sample today! https://www.arizton.com/market-reports/epinephrine-auto-injector-market
Market Segmentation by Geography
-- Europe
-- Spain
-- Germany
-- Netherlands
-- France
-- UK
-- North America
-- US
-- Canada
-- APAC
-- South Korea
-- Japan
-- Australia
-- Latin America
-- Brazil
-- Argentina
-- MEA
-- Turkey
-- Israel
-- South Africa
Major Vendors
-- Mylan
-- Teva Pharmaceutical Industries
-- Amneal Pharmaceuticals
Other vendors include - Adamis Pharmaceuticals, ALK-Abelló, Bioprojet PHARMA, Bausch & Lomb, kaléo, and Novartis.
Explore our healthcare & lifesciences profile to know more about the industry.
Read some of the top-selling reports:
-- Telehealth Market in US - Industry Outlook and Forecast 2020-2025
-- Central Intravenous Catheter Market - Global Outlook and Forecast
2020-2025
-- Peripheral Intravenous Catheters Market - Global Outlook and Forecast
2020-2025
-- Medical Linear Accelerators Market - Global Outlook and Forecast
2020-2025
About Arizton:
Arizton Advisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services.
We offer comprehensive market research reports on industries such as consumer goods & retail technology, automotive and mobility, smart tech, healthcare, and life sciences, industrial machinery, chemicals and materials, IT and media, logistics and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.
Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.
Mail: enquiry@arizton.com
Call: +1-312-235-2040
+1-302-469-0707
View original content:http://www.prnewswire.com/news-releases/the-global-epinephrine-auto-injector-market-to-reach-revenues-of-over-2-billion-during-the-period-2020-2025---market-research-by-arizton-301046100.html
SOURCE Arizton Advisory & Intelligence
